We improve the quality of life by creating new medicines
RUS | ENG
+7 (495) 925-30-74
  • About us
    • History
    • Structure
    • Management
  • Manufacturing
    • API & FDF Experimental Producton
    • Biotechnological Producton (BioIntegrator)
  • Portfolio
    • BioIntegrator
    • Viriom
    • Chromis
    • Aviron, Avivir
    • CardioSystemPharma
    • NewVac
    • Avineuro
  • Business Incubator
    • For Leasees
    • Laboratory Furniture
    • Conference room
    • Corporate Hotel “House of Scientists”
  • News
  • Contacts
+7 (495) 925-30-74
  • About us
    • History
    • Structure
    • Management
  • Manufacturing
    • API & FDF Experimental Producton
    • Biotechnological Producton (BioIntegrator)
  • Portfolio
    • BioIntegrator
    • Viriom
    • Chromis
    • Aviron, Avivir
    • CardioSystemPharma
    • NewVac
    • Avineuro
  • Business Incubator
    • For Leasees
    • Laboratory Furniture
    • Conference room
    • Corporate Hotel “House of Scientists”
  • News
  • Contacts
+7 (495) 925-30-74
Home >> Gallery >> 2014

2014

VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW
VIEW

COMPANY NEWS

24.03.2021 Avifavir obtains its first registration in Asia
10.03.2021 Chromis published results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021
20.11.2020 The international expert community highlights the efficacy and safety of Avifavir in COVID-19 treatment
09.11.2020 Avifavir will be made available to outpatients free of charge for the treatment of COVID-19
24.09.2020 RDIF and ChemRar to supply Avifavir to 17 countries
all news
Copyright © 2021 HTC "Chemrar"